{"disease":{"id":"hepatic-impairment-renal-impairment","name":"hepatic impairment renal impairment"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02998775","title":"Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Eisai Inc.","has_results":false},{"nct_id":"NCT05112419","title":"A Study to Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"AstraZeneca","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}